Nofazinlimab Biosimilar (PDCD1 / PD-1 / CD279 Reference Antibody)
Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research.
Product Specifications
Target
Nofazinlimab Biosimilar (Anti-PDCD1 / PD-1 / CD279 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cancer Biology; Immunology & Inflammation; Cell Biology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042379-100 1x 100 µL
HER-4 / ERBB4 (HFR-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
